Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Mabthera SC
Rituximab 1600mg/13.4mL
Solution for injection
Roche Products (NZ) Limited
F Hoffmann-La Roche Limited, Kaiseraugst, Switzerland
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Maxigesic PE (General sale)
Ibuprofen 150mg
Paracetamol 500mg
Phenylephrine hydrochloride 2.5mg
Film coated tablet
AFT Pharmaceuticals Limited
Sigma Laboratories Limited, Mapusa, India
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Maxigesic PE (Pharmacy only)
Ibuprofen 150mg
Paracetamol 500mg
Phenylephrine hydrochloride 2.5mg
Film coated tablet
AFT Pharmaceuticals Limited
Sigma Laboratories Limited, Mapusa, India
|
Dated this 7th day of July 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz